[HTML][HTML] Efficacy of antibodies and antiviral drugs against Covid-19 Omicron variant
E Takashita, N Kinoshita, S Yamayoshi… - … England Journal of …, 2022 - Mass Medical Soc
E Takashita, N Kinoshita, S Yamayoshi, Y Sakai-Tagawa, S Fujisaki, M Ito…
New England Journal of Medicine, 2022•Mass Medical SocMonoclonal Antibody and Antiviral Activity against Omicron Investigators assessed the in
vitro activities of seven monoclonal antibodies and three antiviral drugs against Covid-19
variants of concern. All the antibodies showed either no or weak neutralizing activity against
the omicron variant; two agents that target the RNA polymerase and a protease inhibitor
were effective at omicron neutralization.
vitro activities of seven monoclonal antibodies and three antiviral drugs against Covid-19
variants of concern. All the antibodies showed either no or weak neutralizing activity against
the omicron variant; two agents that target the RNA polymerase and a protease inhibitor
were effective at omicron neutralization.
Monoclonal Antibody and Antiviral Activity against Omicron
Investigators assessed the in vitro activities of seven monoclonal antibodies and three antiviral drugs against Covid-19 variants of concern. All the antibodies showed either no or weak neutralizing activity against the omicron variant; two agents that target the RNA polymerase and a protease inhibitor were effective at omicron neutralization.
The New England Journal Of Medicine